Advertisement
CELZ Forex News
Creative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell Therapy
Biotechnology company Creative Medical Technology Holdings, Inc. (CELZ) announced Tuesday that it has received Institutional Review Board (IRB) approval to proceed with its clinical trial for the treatment of chronic lower back pain with its StemSpine procedure using AlloStem (CELZ-201-DDT) cell therapy.
RTTNews
|
635 days ago